Key result
Supraventricular tachycardia affects 1 in 500 children and is managed acutely with vagal maneuvers or cardioversion, and long-term with antiarrhythmic drugs, catheter ablation, or surgery.
Why the study?
This article reviews the etiology, pathophysiology, types, clinical presentation, diagnosis, and treatment of supraventricular tachycardia in children.
Population
Children with supraventricular tachycardia
Design
Review
Authors
Loading...
Clinicians may reference established SVT options in children; leaves open need for comparative trials on long-term outcomes.
This review provides a comprehensive overview of the etiology, diagnosis, and management of supraventricular tachycardia in pediatric patients.
Garcia et al. (2024) conducted a review in Supraventricular tachycardia. Supraventricular tachycardia was evaluated. Supraventricular tachycardia affects 1 in 500 children and is managed acutely with vagal maneuvers or cardioversion, and long-term with antiarrhythmic drugs, catheter ablation, or surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: